Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi India Ltd Major Shareholding Notification 2021

Nov 10, 2021

59270_rns_2021-11-10_e2ddccb9-2488-4464-b63a-1233ce2a97a0.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Central Office, Investment Dept., 'Yogakshema' 6th Floor, Jeevan Bima Marg, Mumbai: 400021
Ph: 022 -66598851/ 26/38/ 47/ Fax: 22825411

Ref: Inv/Back Office

Date-10.11.2021

The Company Secretary SANOFI INDIA LTD. Sanofi House, 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai Maharashtra -400072 Dear Sir,

Re: Disclosures under Regulation 29(2) the SEBI (Substantial Acquisition of shares and takeovers) Regulations, 2011.

We are sending herewith the disclosures as required under above mentioned SEBI regulations for a person holding more than 5% shares in a listed company. For your information we are also providing our DP IDs, Client IDs & PAN number.

Yours faithfully,

Asst. Secretary (Investment- M&A)

    1. BSE Ltd, Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001.
    1. NSE Ltd, Bandra Kurla Complex, Bandra (E), Mumbai 400 051. Encls: As above

Annexure 2 Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Share and

Takeover) Regulations, 2011

Name of the Target Company (TC) SANOFI INDIA LTD
Name(s) of the acquirer and Persons
Acting in Concert (PAC) with the
Acquirer
Life Insurance Corporation of India
Central Office, Yogakshema 6 th Floor,
Mumbai- 400021.
022-66598626/8851
Whether the acquirer belongs to
Promoter/Promoter group
No
Name(s) of the Stock Exchange(s)
where the shares of TC are Listed
NSE
Details of the acquisition /
disposal/holding of shares/voting
rights/holding of the Acquirer and
PAC
Number % w.r.t.total
share/voting
capital
wherever
applicable
% w.r.t. total
diluted
share/voting
capital of the
$TC$ $(*)$
Before the acquisition/disposal under
consideration, holding of:
a) Shares carrying voting rights
b) Voting rights (VR) otherwise
than by shares
c) Warrants/convertible
securities/any other instrument
that entitles the acquirer to
receive shares carrying voting
rights in the T C (specify holding
in each category)
707,656 $3.073\%$ NA
Total $(a+b+c)$ 707,656 1
3.073%
Details of acquisition/sale
a) Shares carrying voting rights
acquired/sold
b) VRs acquired /sold otherwise
than by shares
c) Warrants/convertible
securities/any other instrument that
entitles the acquirer to
receive shares carrying voting
rights in the TC (specify holding
in each category) acquired/sold
470,529 / 2.043%
Total $(a+b+c)$ $470,529$ $\sqrt{ }$ 2.043%
$\sqrt{2}$
After the acquisition/sale, holding of:

a) Shares carrying voting rights
b) VRs otherwise than by shares
c) Warrants/convertible
securities/any other instrument
that entitles the acquirer to
receive shares carrying voting
rights in the TC (specify holding
in each category) after
Acquisition.
1,178,185 5.116%
Total (a+b+c) 1,178,185 $5.116\%$ /
Mode of acquisition / sale (e.g. open
market / off-market / public issue /
rights issue / preferential allotment /
Inter-se transfer etc).
MARKET PURCHASE
Date of acquisition / sale of shares /
VR or date of receipt of intimation of
allotment of shares, whichever is
applicable
$29.12.2020 - 09.11.2021$
Equity share capital / total voting
capital of the TC before the said
acquisition / sale
230,306,220
Equity share capital/ total voting
capital of the TC after the said
acquisition / sale
230,306,220
Total diluted share/voting capital of
The TC after the said acquisition/sale.
NA

(*) Diluted share/voting capital means the total number of shares in the TC assuming full
Conversion of the outstanding convertible securities/warrants into equity shares of the TC.

$M\mathcal{V}$

Signature of the acquirer / seller / Authorised Signatory

Place: MUMBAI

Date: 10.11.2021